Neuronal Nitric Oxide Synthase (nNOS or NOS1) is an important enzyme in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
[^3]
| NOS1 |
|---|
| Neuronal Nitric Oxide Synthase |
| Gene | NOS1 |
| UniProt | P70689 (mouse), Q9WU75 (rat) |
| Molecular Weight | ~160 kDa |
| Subcellular Localization | Cytoplasm, Membrane |
Neuronal nitric oxide synthase (NOS1) is a calcium-calmodulin dependent enzyme that produces nitric oxide (NO) in the nervous system. NO is a versatile signaling molecule involved in synaptic plasticity, blood flow regulation, and immune responses. Dysregulation of NOS1 contributes to neuroinflammation and neuronal death in several neurodegenerative conditions.
NOS1 has a complex multi-domain structure:
¶ Functional Domains
- N-terminal PDZ domain: Localizes to synaptic membranes
- Oxygenase domain: Contains heme and substrate binding sites
- Calmodulin-binding domain: Calcium-dependent activation
- Reductase domain: NADPH and FAD binding
- nNOSμ: Full-length neuronal isoform
- nNOSβ: Truncated isoform
- nNOSγ: Testis-specific isoform
- Synaptic plasticity: Mediates LTP and LTD
- Neurotransmission: Modulates release of neurotransmitters
- Blood flow: Regulates cerebral vasodilation
- Development: Axon guidance
- NO as second messenger
- cGMP-dependent pathways
- S-nitrosylation of proteins
- Reactive nitrogen species
- Long-range signaling
- Activity-dependent release
- Circuit-specific effects
- Amyloid-beta interaction: nNOS-derived NO enhances Aβ toxicity
- Tau phosphorylation: NO signaling affects tau kinases
- Synaptic dysfunction: NO modulates synaptic proteins
- Neuroinflammation: Glial NO production
- NOS1 inhibitors: Potential AD treatment
- Selective targeting needed
- Blood-brain barrier considerations
- Oxidative stress: NO contributes to ROS
- Mitochondrial dysfunction: NO affects Complex I
- Neuroinflammation: Microglial NO production
- Excitotoxicity: NMDA receptor modulation
- NOS1 polymorphisms and PD risk
- Gene expression changes
- Interaction with PINK1/Parkin
- Motor neuron toxicity
- Astrocyte involvement
- Astrocyte-specific NOS1
- Excitotoxic mechanisms
- Calmodulin activation
- NMDA receptor coupling
- Activity-dependent release
- L-arginine dependence
- Tetrahydrobiopterin (BH4)
- Heme availability
- Peroxynitrite formation (NO + O₂⁻)
- Lipid peroxidation
- DNA damage
- Protein nitration
- Tyrosine nitration
- S-nitrosylation
- Altered protein function
- Selective NOS1 inhibitors
- NO scavengers
- Calcium channel modulators
- Antioxidants
- Normal NO function
- Blood-brain barrier
- Peripheral side effects
- Isoform specificity
- Knockout mice: Protective in some models
- Transgenic overexpression: Neurodegeneration
- Astrocyte-specific models
- In vitro neuronal cultures
- CSF nitrite/nitrate
- S-nitrosylated proteins
- Peripheral blood cells